tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABUS Stock Latest News

ABUS Upcoming Earnings Report: What to Expect?
Pre-EarningsABUS Upcoming Earnings Report: What to Expect?
9d ago
ABUS
Arbutus Biopharma’s Long-Term Hepatitis B Study: A Potential Game-Changer for Investors
PremiumCompany Announcements
Arbutus Biopharma’s Long-Term Hepatitis B Study: A Potential Game-Changer for Investors
16d ago
ABUS
Arbutus Biopharma Showcases Data at Liver Meeting 2025
PremiumCompany Announcements
Arbutus Biopharma Showcases Data at Liver Meeting 2025
1M ago
8K
ABUS
Arbutus Biopharma to present imdusiran, AB-101 data at The Liver Meeting 2025
PremiumThe Fly
Arbutus Biopharma to present imdusiran, AB-101 data at The Liver Meeting 2025
1M ago
ABUS
Arbutus Biopharma’s Patent Ruling in Pfizer Lawsuit
PremiumCompany Announcements
Arbutus Biopharma’s Patent Ruling in Pfizer Lawsuit
2M ago
8K
ABUS
Arbutus Biopharma Reports Strong Revenue Growth in Q2 2025
PremiumCompany AnnouncementsArbutus Biopharma Reports Strong Revenue Growth in Q2 2025
3M ago
ABUS
Arbutus Biopharma Appoints New Board Member Amid Strong Q2
Premium
Company Announcements
Arbutus Biopharma Appoints New Board Member Amid Strong Q2
3M ago
8K
ABUS
Arbutus Biopharma reports Q2 EPS 1c vs (11c) last year
Premium
The Fly
Arbutus Biopharma reports Q2 EPS 1c vs (11c) last year
3M ago
ABUS
Arbutus Biopharma’s AB-101 Study: A Potential Game-Changer in Chronic Hepatitis B Treatment
PremiumCompany Announcements
Arbutus Biopharma’s AB-101 Study: A Potential Game-Changer in Chronic Hepatitis B Treatment
4M ago
ABUS
Arbutus Biopharma Ends Partnership with Qilu Pharmaceutical
PremiumCompany Announcements
Arbutus Biopharma Ends Partnership with Qilu Pharmaceutical
5M ago
8K
ABUS
Arbutus Biopharma reacquires Greater China rights to imdusiran, forms SAB
PremiumThe Fly
Arbutus Biopharma reacquires Greater China rights to imdusiran, forms SAB
5M ago
ABUS
Arbutus Biopharma Holds Annual Shareholder Meeting
PremiumCompany Announcements
Arbutus Biopharma Holds Annual Shareholder Meeting
6M ago
8K
ABUS
Mount Logan Capital Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsMount Logan Capital Reports Q1 2025 Financial Results
6M ago
ABUS
Arbutus Biopharma Achieves Milestones in Hepatitis B Treatment and Expands Leadership
Premium
Company Announcements
Arbutus Biopharma Achieves Milestones in Hepatitis B Treatment and Expands Leadership
6M ago
ABUS
Arbutus Biopharma reports Q1 EPS (13c), consensus (15c)
Premium
The Fly
Arbutus Biopharma reports Q1 EPS (13c), consensus (15c)
6M ago
ABUS
Arbutus Biopharma Unveils Promising HBV Treatment Data
PremiumCompany Announcements
Arbutus Biopharma Unveils Promising HBV Treatment Data
6M ago
8K
ABUS
Arbutus Biopharma presents data from two HBV assets
PremiumThe Fly
Arbutus Biopharma presents data from two HBV assets
6M ago
ABUS
Arbutus Biopharma Showcases Promising Hepatitis B Treatments at EASL Congress 2025
PremiumCompany Announcements
Arbutus Biopharma Showcases Promising Hepatitis B Treatments at EASL Congress 2025
7M ago
ABUS
Arbutus Biopharma Faces Executive Changes Amid Legal Battle
PremiumCompany Announcements
Arbutus Biopharma Faces Executive Changes Amid Legal Battle
7M ago
8K
ABUS
Arbutus Biopharma’s Strategic Restructuring and Legal Prospects Justify Buy Rating
PremiumRatingsArbutus Biopharma’s Strategic Restructuring and Legal Prospects Justify Buy Rating
8M ago
ABUS
Arbutus Biopharma Announces 2024 Financial Results and Strategic Restructuring
Premium
Company Announcements
Arbutus Biopharma Announces 2024 Financial Results and Strategic Restructuring
8M ago
ABUS
Arbutus Biopharma reduced workforce by 57%
Premium
The Fly
Arbutus Biopharma reduced workforce by 57%
8M ago
ABUS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >